MedPath

Novasit-M 50/1000

Brand Name: Novasit-M 50/1000

Generic Name: Sitagliptin (as phosphate monohydrate) + Metformin hydrochloride.

Active
Registration Number

DRP-15251

Dosage Form

Film-Coated Tablet

Issuance Date

May 31, 2024

Expiry Date

May 31, 2026

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength50 mg/1 g
PackagingAlu/Alu Blister Pack x 7's (Box of 28's)

Classification

C
Classification
Prescription (Rx) Drug
P
Pharmacologic
Blood Glucose Lowering Drug Combination
A
Application
Initial
Philippine FDA Classification

Active Ingredients (2)

Complete list of active ingredients in this pharmaceutical product.

Sitagliptin (as phosphate monohydrate)Active
Monograph: sitagliptin (as phosphate monohydrate)
Metformin hydrochloride.Active
Monograph: metformin hydrochloride.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform